3
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Verification of Decreased Basal and Stimulated Serum Pepsinogen-I Levels Is a Useful Non-Invasive Method for Determining the Success of Eradication Therapy for Helicobacter pylori

, , , , , & show all
Pages 103-110 | Received 08 May 1995, Accepted 18 Jul 1995, Published online: 08 Jul 2009

References

  • Isenberg JI, McQuaid KR, Laine L, Rubin W. Acid-peptic disorders. Textbook of gastroenterology. Vol I., T Yamada, DH Alpers, C Owyang, DW Powell, FE Silverstein. JB Lippincott, Philadelphia 1991; 1241–339
  • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311–4
  • Rotter JI, Sones JQ, Samloff IM, Richardson CT, Gursky UM, Walsh JH. Duodenal ulcer disease associated with elevated serum pepsinogen I. An inherited autosomal dominant disorder. N Engl J Med 1979; 300: 63–6
  • Rotter JI, Petersen G, Samloff IM, McConnell RB, Ellis A, Spence A. Genetic heterogenity of hiperpepsinogenemic I and normopepsinogenemic I duodenal ulcer disease. Ann Intern Med 1979; 91: 372–6
  • Soll AH. Gastric, duodenal, and stress ulcer. Gastrointestinal disease: pathophysiology, diagnosis, management, MH Sleisenger, JS Fordtran. WB Saunders, Philadelphia 1993; 580–602
  • Rotter JI, Rimoin DL. Peptic ulcer disease—a heterogeneous group of disorders. Gastroenterology 1977; 73: 604–8
  • Samloff IM, Taggart RT. Pepsinogens pepsins and peptic ulcer. Clin Invest Med 1987; 10: 215–20
  • Sainz R, Montoro M, Gomollon F. Ulcera duodenal. Enfermedades digestivas, F Vilardel, J Rodés, SR Malagelada, E Moreno, JM Pajares, Mota A Pérez. Ediciones CEA, Madrid 1990; 721–44
  • McNulty CAM, Watson DM. Spiral bacteria of the gastric antrum. Lancet 1984; 1: 1068–73
  • Marshall BJ, McGechie DB, Rogers PA, Glancy RJ. Pyloric campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142: 439–44
  • Humphreys H, Bourke S, Dooley C, McKenna D, Power B, Keane CT. Effect of treatment on Campylobacter pylori in peptic disease. A randomised prospective trial. Gut 1988; 29: 279–83
  • Dooley CP, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108: 70–9
  • Tytgat GNJ, Axon ATR, Dixon MF, Graham DY, Lee A, Marshall BJ. Helicobacter pylori: causal agent in peptic ulcer disease. Working Party Reports, Sydney 1990; 36–45
  • Buck GE, Gourley WK, Lee WK, Subramanyam K, Latimer JM, Dinuzzo AR. Relation of Campylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis 1986; 153: 664–9
  • Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993; 6: 76–9
  • Rangachari PK. Helicobacter pylori and hypergastrinaemia: the quisling option. Scand J Gastroenterol 1991; 26: 85–9, Suppl 187
  • Oderda G, Vaira D, Holton J, Ainley C, Altare F, Ansaldi N. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; 1: 690–2
  • Oderda G, Vaira D, Dell'Olio D, Holton J, Fomi M, Altare F. Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori. J Clin Pathol 1990; 43: 762–5
  • Mossi S, Meyer-Wyss B, Rener EL, Merki HS, Gamboni G, Beglinger C. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcer. Gut 1993; 34: 752–5
  • Oderda G, Vaira D, Holton J, Dowsett JF, Ansaldi N. Serum pepsinogen I and IgG antibody to Campylobacter pylori in nonspecific abdominal pain in childhood. Gut 1989; 30: 912–6
  • Chittajallu RS, Dorrian CA, Ardill JE, McColl KE. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992; 27: 20–3
  • Oderda G, Dell'Olio D, Lerro P, Ajtare F, Moora I, Ansaldi N. Campylobacter pylori and serum pepsinogen I in children. Gut 1988; 29: A1460
  • Veenendaal RA, Biemond I, Pe$ń AS, Duijn W, Van Kreuning J, Lamers CPHW. Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 1992; 33: 452–5
  • Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T. Relationship for Helicobacter pylori to serum pepsinogen in a asymptomatic Japanese population. Gastroenterology 1992; 102: 760–4
  • Gisbert JP, Boixeda D, Vila T, Martin de Argila C, Canton R, Alvarez Baleriola I. Correlación de los niveles basales de pepsinógeno I con el diagnóstico microbiológico de Helicobacter pylori y con el diagnóstico histológico. Rev Esp Enferm Dig 1993; 83: 58, Suppl 1
  • Gisbert JP, Boixeda D, Vila T, Martin de Argila C, Ruiz del Arbol L, De Rafael L. Relación entre los niveles basales de pepsinógeno I y la infección por Helicobacter pylori. Rev Esp Enferm Dig 1993; 83: 57–8, Suppl I
  • Gisbert JP, Boixeda D, Vila T, De Rafael L, Redondo C, Martin de Argila C. Niveles basales de pepsinógeno I sérico e infección por Helicobacter pylori en pacientes con úlcera duodenal y endoscopia normal. Rev Esp Enferm Dig., In press
  • Hengels KJ, Jablonowski K, Schumacher B, Porschen R, Cooreman M, Borchard F. Serum pepsinogens: sensitive indicators of gastritis activity. Rev Esp Enferm Dig 1990; 78: 79, Suppl 1
  • Fraser AG, Prewett EJ, Pounder RE, Samloff IM. Twenty-four-hour hyperpepsinogenaemia in Helicobacter pylori-positive subjects is abolished by eradication of the infection. Aliment Pharmacol Ther 1992; 6: 389–92
  • Boixeda D, Gisbert JP, Vila T, Canton R, Arocena C, Garcia Gonzalez M. Decrease in basal levels of pepsinogen I after eradication of Helicobacter pylori. VIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Acta Gastroenterol Belg 1993; 56: 130
  • Hunter FM, Correa P, Fontham E, Ruiz B, Sobhan M, Samloff IM. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci 1993; 38: 2081–6
  • Albillos A, Alvarez-Mon M, Rossi I, Gonzalo MA, Marin MC, Abreu L. Different HCI and pepsinogen I secretion patterns in anatomically defined gastric ulcer subsets. Am J Gastroenterol 1990; 85: 535–8
  • Waldum HL, Burhol PG, Straume BK. Serum group I pepsinogens during prolonged infusion of pentagastrin and secretin in man. Scand J Gastroenterol 1979; 14: 761–3
  • Waldum HL, Burhol PG, Straume BK. Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneus injection of pentagastrin. Scand J Gastroenterol 1978; 13: 943–6
  • Ten Kate RW, Tuynman H, Festen HPM, Pals G, Meuwissen SGM. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man. Hepatogastroenterology 1990; 37: 124–8
  • Äärimaa M, Härkonen M, Varis K, Inberg M, Karonen SL. Serum group I pepsinogen during insulin and pentagastrin test in unoperated and vagotomized duodenal ulcer patients. Scand J Gastroenterol 1987; 22: 956–8
  • Samloff IM, Secrist DM, Passaro E. The effect of betazole on serum group I pepsinogen levels: studies in symptomatic patients with and without recurrent ulcer after vagotomy and gastric resection or drainage. Gastroenterology 1976; 70: 1007–9
  • Samloff IM, Secrist DM, Passaro E. The effect of betazole on serum group I pepsinogen levels: relationship to gastric acid output in unoperated and postoperative patients. Gastroenterology 1977; 72: 845
  • Hall DWR. Review of the modes of action of colloidal bismuth subcitrate. Scand J Gastroenterol 1988; 24: 3–7, Suppl 157
  • Lomas RW, Smith L. Medical treatment of peptic ulcer disease. Curr Opin Gastroenterol 1992; 8: 934–53
  • Chittajallu RS, Neithercut WD, Ardill JES, McColl KEL. Helicobacter pylori-related hypergastrinaemia is not due to elevated of antral surface pH. Studies with antral alkalinisation. Scand J Gastroenterol 1992; 27: 218–20
  • Forrest JAH, Fettes MR, McLoughlin GP, Heading RC. Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. Gut 1979; 20: 404–7
  • Oderda G, Vaira D, Holton J, Ainley C, Altare F, Boero M. Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci 1991; 36: 572–6
  • Jones DM, Eldridge J, Fox AJ, Sethi P, Whorwell PJ. Antibody to the gastric Campylobacter-like organism (‘Campylobacter pyloridis’). Clinical correlations and distribution in the normal population. J Med Microbiol 1986; 22: 57–60
  • Graham D, Klein PD, Evans DJ, Evans DG, Alpert LC, Opekun AR. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1987; 1: 1174–6
  • Marshall BJ, Surveyor I. Carbon-14 urea breath test for the diagnosis of Campylobacter pylori-associated gastritis. J Nucl Med 1988; 29: 11–3
  • Evans DJ, Evans DG, Graham DY, Klein PD. A sensitive and specific serological test for detection of Campylobacter pylori infection. Gastroenterology 1989; 96: 1004–6
  • Schrader JA, Peck HV, Notis WM, Shaw P, Venezia RA. A role for culture in diagnosis of Helicobacter pylori-related gastric disease. Am J Gastroenterol 1993; 88: 1729–32
  • Marshall BJ. Campylobacter pyloridis and gastritis. J Infect Dis 1986; 153: 650–7
  • Cave TR, Cave DR. A Helicobacter pylori peptide increases pepsinogen secretion from isolated rabbit gastric glands. Rev Esp Enferm Dig 1990; 78: 52–4, Suppl 1
  • Mertz HR, Samloff IM, Rotter J, Peterson W, Walsh J. Helicobacter pylori seropositivity in a hyperpepsinogen I family. Gastroenterology 1991; 100: A12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.